MedTrace Logo

The Effect of Dexmedetomidine on Brachial Plexus Block for Shoulder Surgery

NCT02225054 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2017-11-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether a small dose of Dexmedetomidine, when given either intravenously or as part of the interscalene nerve block solution, prolongs pain relief following shoulder surgery compared to local anesthetic solution alone.

Conditions

  • Nerve Pain
  • Shoulder Pain

Interventions

DRUG

Dexmedetomidine

0.5 u/kg Dexmedetomidine diluted in saline to 1 mL (single interscalene injection) Dexmedetomidine 0.5 u/kg as a single IV bolus over 30 minutes following GA induction

DRUG

Ropivacaine

15 ml 0.5%

DRUG

Normal Saline

1 mL 0.9%

Sponsors & Collaborators

  • Women's College Hospital

    lead OTHER

Principal Investigators

  • Richard M. Brull, MD, FRCPC · University of Toronto, Women's College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02225054 on ClinicalTrials.gov